Mesenchymal Stromal Cell-Derived Extracellular Vesicles for Neonatal Lung Disease: Tiny Particles, Major Promise, Rigorous Requirements for Clinical Translation
Extreme preterm birth disrupts late lung development and puts newborns at risk of developing chronic lung disease, known as bronchopulmonary dysplasia (BPD). BPD can be associated with life-long complications, and currently no effective treatment is available. Cell therapies are entering the clinics...
Main Authors: | Flore Lesage, Bernard Thébaud |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/7/1176 |
Similar Items
-
Mesenchymal Stromal Cell-Derived Extracellular Vesicles in Wound Healing
by: Arulkumar Nallakumarasamy, et al.
Published: (2022-10-01) -
Therapeutic Implications of Mesenchymal Stromal Cells and Their Extracellular Vesicles in Autoimmune Diseases: From Biology to Clinical Applications
by: Angelos Matheakakis, et al.
Published: (2021-09-01) -
Lung Fibrosis Is Improved by Extracellular Vesicles from IFNγ-Primed Mesenchymal Stromal Cells in Murine Systemic Sclerosis
by: Pauline Rozier, et al.
Published: (2021-10-01) -
Extracellular Vesicle-Dependent Communication Between Mesenchymal Stromal Cells and Immune Effector Cells
by: Riccardo Bazzoni, et al.
Published: (2020-11-01) -
Mesenchymal Stem Cell-Derived Extracellular Vesicles for the Treatment of Bronchopulmonary Dysplasia
by: Yufeng Xi, et al.
Published: (2022-04-01)